Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas

European Journal of Endocrinology

Volumn 172, Issue 5, 2015, Pages 603-608

  Gomes, D C ^a,b   Jamra, S A ^a   Leal, L F ^a   Colli, L M ^a   Campanini, M L ^a   Oliveira, R S ^a   Martinelli, C E ^a   Moreira, A C ^a   Machado, H R ^a   Saggioro, F ^a   Neder, L ^a   Castro, M ^a   Antonini, S R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; KI 67 ANTIGEN; MESSENGER RNA; PROTEIN PATCHED 1; SMOOTHENED PROTEIN; SONIC HEDGEHOG PROTEIN; TRANSCRIPTION FACTOR GLI1; TRANSCRIPTION FACTOR GLI2; TRANSCRIPTION FACTOR GLI3; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; SHH PROTEIN, HUMAN;

ADAMANTINOMATOUS CRANIOPHARYNGIOMA; ADOLESCENT; ADULT; ARTICLE; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CRANIOPHARYNGIOMA; CTNNB1 GENE; DISEASE FREE SURVIVAL; ENZYME ACTIVATION; FEMALE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC IDENTIFICATION; GLI1 GENE; GLI2 GENE; GLI3 GENE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PTCH1 GENE; REAL TIME POLYMERASE CHAIN REACTION; SHH GENE; SIGNAL TRANSDUCTION; SMO GENE; SUFU GENE; UPREGULATION; BIOSYNTHESIS; GENETICS; HYPOPHYSIS TUMOR; METABOLISM; MUTATION; YOUNG ADULT;

ADOLESCENT; ADULT; BETA CATENIN; CHILD; CRANIOPHARYNGIOMA; FEMALE; HEDGEHOG PROTEINS; HUMANS; MALE; MUTATION; PITUITARY NEOPLASMS; RECEPTOR CROSS-TALK; RNA, MESSENGER; SIGNAL TRANSDUCTION; UP-REGULATION; YOUNG ADULT;

EID: 84929501936     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-14-0934     Document Type: Article

References (24)

1. Muller HL. Craniopharyngioma. Endocrine Reviews 2014 35 513-543. (doi:10.1210/er.2013-1115)
2. Larkin SJ & Ansorge O. Pathology and pathogenesis of craniopharyngiomas. Pituitary 2013 16 9-17. (doi:10.1007/s11102-012-0418-4)
3. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW& Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathologica 2007 114 97-109. (doi:10.1007/s00401-007-0243-4)
4. Muller HL. Childhood craniopharyngioma-current concepts in diagnosis, therapy and follow-up. Nature Reviews. Endocrinology 2010 6 609-618. (doi:10.1038/nrendo.2010.168)
5. Buslei R, Nolde M, Hofmann B, Meissner S, Eyupoglu IY, Siebzehnrubl F, Hahnen E, Kreutzer J & Fahlbusch R. Common mutations of b-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region. Acta Neuropathologica 2005 109 589-597. (doi:10.1007/s00401-005-1004-x)
6. Colli LM, Saggioro F, Serafini LN, Camargo RC, Machado HR, Moreira AC, Antonini SR & de Castro M. Components of the canonical and non-canonical Wnt pathways are not mis-expressed in pituitary tumors. PLoS ONE 2013 8 e62424. (doi:10.1371/journal.pone.0062424)
7. Brastianos PK, Taylor-Weiner A, Manley PE, Jones RT, Dias-Santagata D, Thorner AR, Lawrence MS, Rodriguez FJ, Bernardo LA, Schubert L et al. Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas. Nature Genetics 2014 46 161-165. (doi:10.1038/ng.2868)
8. Campanini ML, Colli LM, Paixao BM, Cabral TP, Amaral FC, Machado HR, Neder LS, Saggioro F, Moreira AC, Antonini SR et al. CTNNB1 gene mutations, pituitary transcription factors, and micro-RNA expression involvement in the pathogenesis of adamantinomatous craniopharyngiomas. Hormones & Cancer 2010 1 187-196. (doi:10.1007/s12672-010-0041-7)
9. Holsken A, Buchfelder M, Fahlbusch R, Blumcke I & Buslei R. Tumour cell migration in adamantinomatous craniopharyngiomas is promoted by activated Wnt-signalling. Acta Neuropathologica 2010 119 631-639. (doi:10.1007/s00401-010-0642-9)
10. Sekine S, Shibata T, Kokubu A, Morishita Y, Noguchi M, Nakanishi Y, Sakamoto M & Hirohashi S. Craniopharyngiomas of adamantinomatous type harbor b-catenin gene mutations. American Journal of Pathology 2002 161 1997-2001. (doi:10.1016/S0002-9440(10)64477-X)
11. Andoniadou CL, Gaston-Massuet C, Reddy R, Schneider RP, Blasco MA, Le Tissier P, Jacques TS, Pevny LH, Dattani MT & Martinez-Barbera JP. Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma. Acta Neuropathologica 2012 124 259-271. (doi:10.1007/s00401-012-0957-9)
12. Gaston-Massuet C, Andoniadou CL, Signore M, Jayakody SA, Charolidi N, Kyeyune R, Vernay B, Jacques TS, Taketo MM, Le Tissier P et al. Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors inmice and humans. PNAS 2011 108 11482-11487. (doi:10.1073/pnas.1101553108)
13. Andoniadou CL, Matsushima D, Mousavy Gharavy SN, Signore M, Mackintosh AI, Schaeffer M, Gaston-Massuet C, Mollard P, Jacques TS, Le Tissier P et al. Sox2(C) stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential. Cell Stem Cell 2013 13 433-445. (doi:10.1016/j.stem. 2013.07.004)
14. Roessler E, Belloni E, Gaudenz K, Jay P, Berta P, Scherer SW, Tsui LC & Muenke M. Mutations in the human Sonic Hedgehog gene cause holoprosencephaly. Nature Genetics 1996 14 357-360. (doi:10.1038/ ng1196-357)
15. Treier M, Gleiberman AS, OeConnell SM, Szeto DP, McMahon JA, McMahon AP & Rosenfeld MG. Multistep signaling requirements for pituitary organogenesis in vivo. Genes and Development 1998 12 1691-1704. (doi:10.1101/gad.12.11.1691)
16. King P, Paul A & Laufer E. Shh signaling regulates adrenocortical development and identifies progenitors of steroidogenic lineages. PNAS 2009 106 21185-21190. (doi:10.1073/pnas.0909471106)
17. Garcia-Lavandeira M, Saez C, Diaz-Rodriguez E, Perez-Romero S, Senra A, Dieguez C, Japon MA & Alvarez CV. Craniopharyngiomas express embryonic stem cell markers (SOX2, OCT4, KLF4, and SOX9) as pituitary stem cells but do not coexpress RET/GFRA3 receptors. Journal of Clinical Endocrinology and Metabolism 2012 97 E80-E87. (doi:10.1210/jc.2011-2187)
18. Musani V, Gorry P, Basta-Juzbasic A, Stipic T, Miklic P & Levanat S. Mutation in exon 7 of PTCH deregulates SHH/PTCH/SMO signaling: possible linkage to WNT. International Journal of Molecular Medicine 2006 17 755-759. (doi:10.3892/ijmm.17.5.755)
19. Ng JM & Curran T. The Hedgehoges tale: developing strategies for targeting cancer. Nature Reviews. Cancer 2011 11 493-501. (doi:10.1038/nrc3079)
20. Livak KJ & Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(KDelta Delta C(T)) method. Methods 2001 25 402-408. (doi:10.1006/meth.2001.1262)
21. Merchant AA & Matsui W. Targeting Hedgehog-a cancer stem cell pathway. Clinical Cancer Research 2010 16 3130-3140. (doi:10.1158/ 1078-0432.CCR-09-2846)
22. Martinez-Barbera JP& Buslei R. Adamantinomatous craniopharyngioma: pathology, molecular genetics and mouse models. Journal of Pediatric Endocrinology & Metabolism 2015 28 7-17. (doi:10.1515/jpem-2014-0442)
23. Leal LF, Mermejo LM, Ramalho LZ, Martinelli CE Jr, Yunes JA, Seidinger AL, Mastellaro MJ, Cardinalli IA, Brandalise SR, Moreira AC et al. Wnt/b-catenin pathway deregulation in childhood adrenocortical tumors. Journal of Clinical Endocrinology and Metabolism 2011 96 3106-3114. (doi:10.1210/jc.2011-0363)
24. Assie G, Letouze E, Fassnacht M, Jouinot A, Luscap W, Barreau O, Omeiri H, Rodriguez S, Perlemoine K, Rene-Corail F et al. Integrated genomic characterization of adrenocortical carcinoma. Nature Genetics 2014 46 607-612. (doi:10.1038/ng.2953)